Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 28.3× earnings vs its 45.2× historical median P/E.
Fair value ≈ $9.28 · price $5.82 today
Undervalued · 37% below
Loading valuation…
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$EWCZ - European Wax Center Inc - 10K - Updated Risk Factors
EWCZ adds a new risk around its General Atlantic–backed go‑private merger: deal approval and closing are uncertain, could spike stock volatility, impose up to $19M in termination-related costs, constrain operations while pending, trigger litigation and employee/customer disruption, and alter prior tax/TRA expectations. #GoPrivateMerger #DealUncertainty #StockVolatility #TerminationCosts #OperationalConstraints
🟢 Added 🟠 Removed
https://d-risk.ai/EWCZ/10-K/2026-03-04
$EWCZ
Current Stock Price: $5.73
Contracts to trade: $6.0 EWCZ Mar 20 2026 Call
Entry: $0.04
Exit: $0.07
ROI: 98%
Hold ~27 days
Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
$EWCZ Q4 '25 Earnings Results & Recap
For the fourth quarter of fiscal 2025, European Wax Center's total revenue decreased 9.3% to $45.1M, and Adjusted EBITDA decreased 33.1% to $12.7M, resulting in a net loss of $1.5M.
$EWCZ
Current Stock Price: $5.72
Contracts to trade: $6.0 EWCZ Feb 20 2026 Call
Entry: $0.03
Exit: $0.04
ROI: 45%
Hold ~28 days
Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
$AOSL $EWCZ $MBUU $INO
Good morning, investors. Broad selling hit North America as sentiment deteriorated and retail surveys turned more pessimistic. On the watchlist, $AOSL trades near $20.67, down over 43% YTD as losses widen despite AI server exposure. $EWCZ sits at $5.71 with a live takeover bid and slim spread. $MBUU holds near $30.54 with director buying and an expanded buyback. $INO faces legal overhang but has an FDA catalyst ahead. On the downside, $POLX fell −19% after disappointing biotech updates.
Read the full Analytica Alpha 👇
https://analyticainvestor.beehiiv.com/p/silver-drop-hits-juniors
European Wax Center announced a definitive all-cash agreement to be acquired by General Atlantic in a transaction valued at approximately $330 million. Under the terms, General Atlantic will acquire all outstanding Class A shares it does not already own for $5.80 per share, representing a 45% premium to the Feb. 9, 2026 close and a 51% premium to the 90-day volume-weighted average price.
General Atlantic, which already owns about 42% of European Wax Center’s outstanding shares, has been a strategic partner since its initial investment in 2018. The deal was unanimously approved by a special committee of independent directors.
The transaction is expected to close mid-2026, subject to approval by a majority of non-affiliated shareholders and regulatory clearances. Upon completion, European Wax Center will become a private company and its Class A shares will be delisted.
$EWCZ
$EWCZ European Wax Center will go private after investor General Atlantic agreed to buy remaining shares for $5.80 each in cash (about $330M deal). The price is a big premium vs recent stock prices. If approved, the company will delist and close the deal by mid-2026.
PRISM Mid-Day Movers: Biotech and Beauty & Wellness are Today’s Index Leaders.
Quince Therapeutics (Nasdaq: $QNCX) is going parabolic, up about 154% into the high‑$1S as speculation builds around its rare‑disease deal‑making strategy and bone‑targeting NOV004 platform.
European Wax Center (NASDAQ: $EWCZ) jumps roughly 43% into the high‑$3S as investors revisit this 1,000‑location franchised waxing chain as a small‑cap play on recurring beauty services and a potential recovery in discretionary spending.
Other Notable Movers:
Nektar Therapeutics ( $NKTR) up 41%
Microbot Medical Inc. ( $MBOT) up 14%
Lipella Pharmaceuticals ( $LIPO) down -25%
https://prismmarketview.com/prism-mid-day-movers-biotech-and-beauty-wellness-are-todays-index-leaders/
